PAR 7.69% 21.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-1523

  1. 4,362 Posts.
    lightbulb Created with Sketch. 6909
    Ah you guys have it all covered...yup, did not feature on our radar as it failed the primary endpoint. But good that we are all cognizant about the comp./potential competition.

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.